Fujifilm Sonosite Announces iViz in a Newly Defined High Access Mobility Category
Fujifilm Sonosite Announces iViz in a Newly Defined High Access Mobility Category
BOTHELL, WA., November 17, 2015 – FUJIFILM Sonosite Inc., the disruptive specialist in designing cutting-edge ultrasound tools and world-leading education for access to point-of-care visualization, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for iViz, its newest medical visualization solution. First commercialized in Europe, iViz was developed from the ground up to meet the needs of the highly-mobile clinician.
Clinicians do not always treat patients in traditional care settings or have easy access to supporting hospital infrastructure; instead they rely on tools that can easily be carried to help diagnose a patient’s condition. iViz is a powerful new solution for the evolving needs of these point-of-care users. With iViz, clinicians can seamlessly access learning resources and patient information, store exam findings, submit reports, and consult with remote providers for near real-time assessment making it especially suited for field use and for the growing area of telemedicine.